125 related articles for article (PubMed ID: 6703919)
1. Mitoxantrone: a promising new chemotherapeutic agent.
Dalton WS; Alberts DS
Ariz Med; 1984 Feb; 41(2):96-8. PubMed ID: 6703919
[No Abstract] [Full Text] [Related]
2. [Mitoxantrone--a new cytostatic agent].
Klein HO
Fortschr Med; 1985 Feb; 103(8):229-30. PubMed ID: 3979939
[No Abstract] [Full Text] [Related]
3. Mitoxantrone.
Nathanson L
Cancer Treat Rev; 1984 Dec; 11(4):289-93. PubMed ID: 6534511
[No Abstract] [Full Text] [Related]
4. Phase II study of mitoxantrone in advanced breast cancer: an Eastern Cooperative Oncology Group pilot study.
Levin M; Pandya KJ; Khandekar JD; Horton J; Glick JH; Bennett JM; Muggia FM; Falkson G
Cancer Treat Rep; 1984 Dec; 68(12):1511-2. PubMed ID: 6509455
[No Abstract] [Full Text] [Related]
5. Potential cardiotoxicity with mitoxantrone.
Schell FC; Yap HY; Blumenschein G; Valdivieso M; Bodey G
Cancer Treat Rep; 1982 Aug; 66(8):1641-3. PubMed ID: 7105054
[TBL] [Abstract][Full Text] [Related]
6. Phase II evaluation of mitoxantrone in patients with bronchogenic carcinoma: a Southeastern Cancer Study Group trial.
Kramer BS; Gams R; Birch R; Einhorn L; Buchanan R
Cancer Treat Rep; 1984 Oct; 68(10):1295-6. PubMed ID: 6525601
[No Abstract] [Full Text] [Related]
7. Treatment of metastatic sarcomas with mitoxantrone.
Presant CA; Gams R; Bartolucci AA
Cancer Treat Rep; 1984 May; 68(5):813-4. PubMed ID: 6722837
[No Abstract] [Full Text] [Related]
8. Phase II trial of mitoxantrone.
Anderson KC; Cohen GI; Garnick MB
Cancer Treat Rep; 1982 Nov; 66(11):1929-31. PubMed ID: 7139638
[No Abstract] [Full Text] [Related]
9. [Antineoplastic spectrum of mitoxantrone in rat ascitic hepatoma].
Satoh H
Gan To Kagaku Ryoho; 1982 Jan; 9(1):26-30. PubMed ID: 7184361
[TBL] [Abstract][Full Text] [Related]
10. Mitoxantrone in malignant melanoma.
Presant CA; Gams R; Bartolucci A
Cancer Treat Rep; 1984 Jun; 68(6):903-5. PubMed ID: 6733704
[TBL] [Abstract][Full Text] [Related]
11. Phase II trial of mitoxantrone in patients with primary liver cancer.
Falkson G; Coetzer BJ; Terblanche AP
Cancer Treat Rep; 1984 Oct; 68(10):1311-2. PubMed ID: 6525607
[No Abstract] [Full Text] [Related]
12. Mitoxantrone (novantrone): a review of experimental and early clinical studies.
Smith IE
Cancer Treat Rev; 1983 Jun; 10(2):103-15. PubMed ID: 6347376
[No Abstract] [Full Text] [Related]
13. Phase II trial of mitoxantrone in advanced colorectal cancer.
Bonnem EM; Mitchell EP; Woolley PV; Smith FP; Neefe J; Smith L; Schein PS
Cancer Treat Rep; 1982 Nov; 66(11):1995-6. PubMed ID: 7139642
[No Abstract] [Full Text] [Related]
14. Phase II clinical trial of mitoxantrone in patients with advanced renal cell carcinoma: a Southwest Oncology Group study.
Taylor SA; Von Hoff DD; Baker LH; Balcerzak SP
Cancer Treat Rep; 1984 Jun; 68(6):919-20. PubMed ID: 6733708
[No Abstract] [Full Text] [Related]
15. Mitoxantrone for treatment of patients with refractory small cell carcinoma of the lung: a Southwest Oncology Group Study.
Von Hoff DD; Chen T; Clark GM; Callahan SK; Livingston R
Cancer Treat Rep; 1983 Apr; 67(4):403-4. PubMed ID: 6303588
[No Abstract] [Full Text] [Related]
16. Papers presented at a symposium on cancer chemotherapy in the 1980's. Monte Carlo, 11th-12th October, 1984.
Invest New Drugs; 1985; 3(2):79-222. PubMed ID: 3894281
[No Abstract] [Full Text] [Related]
17. Phase II trial of mitoxantrone in previously untreated patients with colorectal adenocarcinoma: A Southwest Oncology Group Study.
Cowan JD; Von Hoff DD; McDonald B; Talley RW; McCracken JD; Chen T
Cancer Treat Rep; 1982 Sep; 66(9):1779-80. PubMed ID: 7116355
[No Abstract] [Full Text] [Related]
18. [Clinical pharmacology of mitoxantrone].
Robak T; Drzewoski J
Pol Tyg Lek; 1985 Dec 23-30; 40(51-52):1473-5. PubMed ID: 3913945
[No Abstract] [Full Text] [Related]
19. Mitoxantrone in patients with acute leukemia in relapse.
Paciucci PA; Ohnuma T; Cuttner J; Silver RT; Holland JF
Cancer Res; 1983 Aug; 43(8):3919-22. PubMed ID: 6861154
[TBL] [Abstract][Full Text] [Related]
20. [The role of chemotherapy in metastatic pulmonary tumors in a disease-oriented phase II study of anticancer agent].
Fujita J; Saijo N
Gan No Rinsho; 1985 Aug; 31(10):1241-6. PubMed ID: 3903252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
